William Blair analyst Matt Phipps initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Outperform rating.
Ready To Trade AMC Heading Into Q4 Earnings? Here’s What The Chart Says
AMC Entertainment Holdings, Inc (NYSE: AMC) was trading down over 3% on Tuesday as the company heads into its fourth-quarter earnings print after the close.